MA
CPIX icon

MUFG Americas’s Cumberland Pharmaceuticals CPIX Stock Holding History

MUFG Americas’s Portfolio CPIX Stock Details CPIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-140
Closed -$1K – 884
2017
Q4 		$1K Sell
140
-90
-39% -$662 ﹤0.01% 999
2017
Q3 		$2K Hold
230
– – ﹤0.01% 1035
2017
Q2 		$2K Hold
230
– – ﹤0.01% 1046
2017
Q1 		$2K Hold
230
– – ﹤0.01% 1038
2016
Q4 		$1K Sell
230
-240
-51% -$1.25K ﹤0.01% 1058
2016
Q3 		$2K Sell
470
-240
-34% -$1.13K ﹤0.01% 1079
2016
Q2 		$3K Hold
710
– – ﹤0.01% 1064
2016
Q1 		$3K Sell
710
-490
-41% -$2.33K ﹤0.01% 1038
2015
Q4 		$6K Buy
+1,200
New +$6.84K ﹤0.01% 899

Other funds holding CPIX

SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return
JAM
JW Asset Management Miami Beach, Florida $244M AUM 71.51% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

MUFG Americas's CPIX Position: Q1 2018 in Review

MUFG Americas sold out of Cumberland Pharmaceuticals (CPIX) in Q1 2018, closing a stake of 140 shares — an estimated $1K sold.

MUFG Americas first reported a position in CPIX in Q4 2015 and held it in 9 quarters. The position peaked at $6K in Q4 2015. 29 funds tracked by Wall St. Rank hold CPIX as of Q1 2018.

  • MUFG Americas reported no remaining Cumberland Pharmaceuticals position as of Q1 2018 after selling out during the quarter.
  • MUFG Americas sold 140 Cumberland Pharmaceuticals shares in Q1 2018, an estimated $1K.
  • MUFG Americas first reported a position in Cumberland Pharmaceuticals in Q4 2015 and held it in 9 quarters.
  • MUFG Americas's Cumberland Pharmaceuticals position peaked at $6K in Q4 2015.
  • 29 funds tracked by Wall St. Rank held Cumberland Pharmaceuticals as of Q1 2018.

Based on MUFG Americas's 13F filing for Q1 2018, filed 7 May 2018.